Global Custom Market Research Reports Provider Company

phone

Geron Corp (GERN) - Medical Equipment - Deals and Alliances Profile

  • Published Date: 07 Sep 2018
  • Number of Pages: 27
  • Category: Company Profile
  • Country: United States of America
Summary

Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. IMbark is a Phase II, randomized, single-blind and multi-center study for patients with high risk myelofibrosis (MF) whose disease is relapsed after or refractory to JAK inhibitor treatment; and IMerge is a Phase 2/3, multi-center study of imetelstat in transfusion-dependent participants with low or intermediate-1 risk myelodysplastic syndrome (MDS). Geron also has collaboration and royalty agreements with companies in oncology, diagnostics, biologics and research tools production domains. Geron is headquartered in Menlo Park, California, the US.

Geron Corp (GERN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Geron Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Geron Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Geron Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Geron Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Geron Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Geron Corp, Medical Equipment, Deal Details 10
GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 10
Equity Offering 11
Geron Plans to Raise up to USD250 Million in Public Offering of Securities 11
Geron to Raise up to USD100 Million in Public Offering of Shares 12
Geron Corp - Key Competitors 13
Geron Corp - Key Employees 14
Geron Corp - Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Financial Announcements 16
Jul 31, 2018: Geron Reports Second Quarter 2018 Financial Results and Recent Company Events 16
May 10, 2018: Geron Reports First Quarter 2018 Financial Results 18
Mar 16, 2018: Geron Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events 19
Nov 01, 2017: Geron Reports Third Quarter 2017 Financial Results 21
Aug 09, 2017: Geron Reports Second Quarter 2017 Financial Results 22
May 09, 2017: Geron Reports First Quarter 2017 Financial Results and Recent Events 23
Mar 01, 2017: Geron Reports Fourth Quarter and Annual 2016 Financial Results 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List Of Tables


Geron Corp, Medical Equipment, Key Facts, 2017 2
Geron Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Geron Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Geron Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Geron Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Geron Corp, Deals By Market, 2012 to YTD 2018 8
Geron Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GE Healthcare Expands Licensing Agreement With Geron For Stem Cell Assays 10
Geron Plans to Raise up to USD250 Million in Public Offering of Securities 11
Geron to Raise up to USD100 Million in Public Offering of Shares 12
Geron Corp, Key Competitors 13
Geron Corp, Key Employees 14

List Of Figures


Geron Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Geron Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Geron Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Geron Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Geron Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Geron Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Geron Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Geron Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

Agfa HealthCare NV (Agfa HealthCare), a subsidiary of Agfa-Gevaert NV, is a healthcare information technology company, which provides eHealth and digital imaging solutions. It provides software for digital radiography, diagnostic

View Report

Micropos Medical AB (Micropos Medical) is a medical device company. The company develops technologies that enhance the precision in radiotherapy of cancer including hypofractionation and stereotactic radio surgery (SRS) and

View Report

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports